Feb 22 (Reuters) - Horizon Pharma PLC HZNP.O :
* Announces that health Canada determines Ravicti(R) (glycerol phenylbutyrate)
oral liquid is eligible for data protection
* Ravicti would be added to register of innovative drugs,receive data
protection for 8 yrs from date of issuance of notice of compliance
* Source text for Eikon ID:nMKWQhFzqa
* Further company coverage HZNP.O